Related Experiment Video
Updated: Jul 25, 2026
09:53
In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
Published on: July 27, 2010
15.9K
FcRγIIA response duality in leishmaniasis.
Ikram Hammi1, Julien Giron-Michel2, Khadija Akarid3
1Health & Environment Laboratory, Ain Chock Faculty of Sciences, Hassan II University of Casablanca (UH2C), Morocco; INSERM UMR-S-MD 1197, Ministère des Armées et Université Paris Saclay, Villejuif, France.
Microbial Pathogenesis
|November 18, 2024
Summary
Leishmania parasites evade host immunity by hijacking immune receptors like Fc gamma receptor IIA (FcγRIIA). Understanding this interaction could reveal new therapeutic targets for leishmaniasis.
Area of Science:
- Immunology
- Parasitology
- Tropical Diseases
Background:
- Leishmania causes a neglected tropical disease impacting millions globally, with potential spread due to climate change.
- The parasite employs sophisticated immune evasion strategies, manipulating host cells and silencing critical immune responses.
- Fc receptors are implicated in microbial immune evasion by promoting inhibitory pathways.
Purpose of the Study:
- To explore the potential role of Fc gamma receptor IIA (FcγRIIA) in leishmaniasis.
- To investigate how Leishmania may utilize FcγRIIA and its downstream signaling pathways for immune evasion.
Main Methods:
- This review synthesizes current knowledge on Leishmania's interaction with host immune receptors.
- Focuses on the specific role of FcγRIIA and associated signaling cascades.
Main Results:
- Leishmania actively manipulates host immune responses early in infection.
- FcγRIIA is identified as a potential key receptor exploited by the parasite.
- Parasite interaction with FcγRIIA may lead to the suppression of essential cellular defenses.
Conclusions:
- Understanding Leishmania's interaction with FcγRIIA offers insights into parasite immune evasion mechanisms.
- Targeting the FcγRIIA pathway presents a potential therapeutic strategy to bolster host immunity against leishmaniasis.
Related Concept Videos
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...